JP2019038772A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019038772A5 JP2019038772A5 JP2017161556A JP2017161556A JP2019038772A5 JP 2019038772 A5 JP2019038772 A5 JP 2019038772A5 JP 2017161556 A JP2017161556 A JP 2017161556A JP 2017161556 A JP2017161556 A JP 2017161556A JP 2019038772 A5 JP2019038772 A5 JP 2019038772A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- amino acid
- amino acids
- target molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001413 amino acids Chemical group 0.000 claims description 28
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 24
- 239000003139 biocide Substances 0.000 claims description 18
- 230000022534 cell killing Effects 0.000 claims description 18
- 235000001014 amino acid Nutrition 0.000 claims description 9
- 150000008574 D-amino acids Chemical class 0.000 claims description 6
- 150000008575 L-amino acids Chemical class 0.000 claims description 6
- 102100029140 Cyclic nucleotide-gated cation channel beta-3 Human genes 0.000 claims description 4
- 101710093675 Cyclic nucleotide-gated cation channel beta-3 Proteins 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 102000004145 Annexin A1 Human genes 0.000 claims description 2
- 108090000663 Annexin A1 Proteins 0.000 claims description 2
- 201000009273 Endometriosis Diseases 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 230000002159 abnormal effect Effects 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 230000004663 cell proliferation Effects 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017161556A JP6613499B2 (ja) | 2017-08-24 | 2017-08-24 | 細胞殺傷剤 |
| SG11202001484QA SG11202001484QA (en) | 2017-08-24 | 2018-08-23 | Cytocidal agent |
| US16/640,248 US11357819B2 (en) | 2017-08-24 | 2018-08-23 | Cytocidal agent |
| CN201880054701.XA CN111065403B (zh) | 2017-08-24 | 2018-08-23 | 细胞杀伤剂 |
| PCT/JP2018/031136 WO2019039540A1 (ja) | 2017-08-24 | 2018-08-23 | 細胞殺傷剤 |
| CA3073392A CA3073392C (en) | 2017-08-24 | 2018-08-23 | Cytocidal agent |
| EP18848077.6A EP3738601A4 (en) | 2017-08-24 | 2018-08-23 | CELL-DESTRUCTIVE AGENT |
| KR1020207004917A KR102427844B1 (ko) | 2017-08-24 | 2018-08-23 | 세포 살상제 |
| AU2018322305A AU2018322305B2 (en) | 2017-08-24 | 2018-08-23 | Cytocidal agent |
| US17/740,864 US20220280596A1 (en) | 2017-08-24 | 2022-05-10 | Cytocidal agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017161556A JP6613499B2 (ja) | 2017-08-24 | 2017-08-24 | 細胞殺傷剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019038772A JP2019038772A (ja) | 2019-03-14 |
| JP2019038772A5 true JP2019038772A5 (OSRAM) | 2019-10-10 |
| JP6613499B2 JP6613499B2 (ja) | 2019-12-04 |
Family
ID=65438932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017161556A Active JP6613499B2 (ja) | 2017-08-24 | 2017-08-24 | 細胞殺傷剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11357819B2 (OSRAM) |
| EP (1) | EP3738601A4 (OSRAM) |
| JP (1) | JP6613499B2 (OSRAM) |
| KR (1) | KR102427844B1 (OSRAM) |
| CN (1) | CN111065403B (OSRAM) |
| AU (1) | AU2018322305B2 (OSRAM) |
| CA (1) | CA3073392C (OSRAM) |
| SG (1) | SG11202001484QA (OSRAM) |
| WO (1) | WO2019039540A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6613499B2 (ja) | 2017-08-24 | 2019-12-04 | 学校法人藤田学園 | 細胞殺傷剤 |
| WO2019138944A1 (ja) | 2018-01-09 | 2019-07-18 | 学校法人藤田学園 | 細胞殺傷剤 |
| WO2022234346A1 (en) * | 2021-05-07 | 2022-11-10 | Twinpig Biolab, Inc. | Peptides targeting macrophages, and conjugates, compositions, and uses thereof |
| CN115725968A (zh) * | 2022-11-18 | 2023-03-03 | 东莞宜安科技股份有限公司 | 一种生物医用钛合金表面的复合涂层及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595756A (en) | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| CA2634934A1 (en) | 2005-12-23 | 2007-07-05 | The Burnham Institute For Medical Research | Endometriosis cell targeting peptide and uses thereof |
| EP2414389A1 (en) * | 2009-04-01 | 2012-02-08 | Schmidt-Wolf, Ingo | Tumor targeting peptides, therapeutic and diagnostic compositions comprising the peptides |
| WO2011027312A1 (en) | 2009-09-03 | 2011-03-10 | Koninklijke Philips Electronics N.V. | NOVEL TUMOR MARKERS SELECTED FROM A GROUP OF cAMP-REGULATORY PATHWAY MEMBERS |
| SG10201704812TA (en) * | 2009-12-23 | 2017-07-28 | Sanford-Burnham Medical Res Inst | Methods and compositions related to annexin 1-binding compounds |
| JP6025707B2 (ja) * | 2010-04-06 | 2016-11-16 | エクソサイト セラピューティクス ピーティイー リミテッド | 癌を治療する方法 |
| US20160067357A1 (en) * | 2012-08-17 | 2016-03-10 | Apellis Pharmaceuticals, Inc. | Detection of high risk drusen |
| US9783576B2 (en) * | 2013-06-11 | 2017-10-10 | Sanford-Burnham Medical Research Institute | Compositions and methods for targeted endometriosis treatment |
| US10338068B2 (en) * | 2013-07-08 | 2019-07-02 | The Trustees Of Columbia University In The City Of New York | Selection of biological objects |
| EP3048167A4 (en) | 2013-09-18 | 2017-03-29 | Kyoto University | Method for creating endometriotic cells and endometriosis model animal |
| JP6862343B2 (ja) | 2014-12-19 | 2021-04-21 | アブリンクス エン．ヴェー． | システイン結合ナノボディダイマー |
| RU2571551C1 (ru) | 2015-04-16 | 2015-12-20 | Закрытое акционерное общество "ПЕПТЕК" | Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором |
| JP2017161556A (ja) | 2017-06-27 | 2017-09-14 | パイオニア株式会社 | 位置認識装置、制御方法、プログラム、及び記憶媒体 |
| JP6613499B2 (ja) | 2017-08-24 | 2019-12-04 | 学校法人藤田学園 | 細胞殺傷剤 |
-
2017
- 2017-08-24 JP JP2017161556A patent/JP6613499B2/ja active Active
-
2018
- 2018-08-23 CA CA3073392A patent/CA3073392C/en active Active
- 2018-08-23 WO PCT/JP2018/031136 patent/WO2019039540A1/ja not_active Ceased
- 2018-08-23 US US16/640,248 patent/US11357819B2/en active Active
- 2018-08-23 KR KR1020207004917A patent/KR102427844B1/ko active Active
- 2018-08-23 CN CN201880054701.XA patent/CN111065403B/zh active Active
- 2018-08-23 SG SG11202001484QA patent/SG11202001484QA/en unknown
- 2018-08-23 AU AU2018322305A patent/AU2018322305B2/en active Active
- 2018-08-23 EP EP18848077.6A patent/EP3738601A4/en active Pending
-
2022
- 2022-05-10 US US17/740,864 patent/US20220280596A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018171063A5 (OSRAM) | ||
| JP2019038772A5 (OSRAM) | ||
| HRP20201353T1 (hr) | Agonisti glukagonskog receptora | |
| JP2017522362A5 (OSRAM) | ||
| HRP20041108B1 (hr) | Peptidi povezani sa tumorom koji se vežu na mhc molekule | |
| JP2014520120A5 (OSRAM) | ||
| AR064555A1 (es) | Peptido wt1 restringido a hla-a*1101 y composicion farmaceutica que comprende el mismo | |
| RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
| JP2013500990A5 (OSRAM) | ||
| RU2016101711A (ru) | Высокостабильный т-клеточный рецептор и способ его получения и применения | |
| JP2011518179A5 (OSRAM) | ||
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| MX2020010806A (es) | Peptidos anti-inflamatorios y usos de los mismos. | |
| JP2015504052A5 (OSRAM) | ||
| JP2013513377A5 (OSRAM) | ||
| JP2019533722A5 (OSRAM) | ||
| CN110799522A (zh) | 用于治疗、改善或预防脑出血的肽及其用途 | |
| JP2017514522A5 (OSRAM) | ||
| JP2006506942A5 (OSRAM) | ||
| SI2797950T1 (en) | Fusion protein against cancer | |
| EA201990885A1 (ru) | Композиции, содержащие короткие пептиды, полученные из pedf, и их применение | |
| HRP20150664T1 (hr) | Antikancerogeni fuzijski protein | |
| JP2019525753A5 (OSRAM) | ||
| JP2018512124A5 (OSRAM) | ||
| WO2017114240A1 (zh) | 一种合成Etelcalcetide的方法 |